ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023

Joint Symposium on Medicinal Chemistry

 Boston, MA, United States    June 10-13, 2023

Session Topics

The conference programme will be built around 9 Sessions:

  • Enabling Chemistries for Chemical Biology Research
    Chair: Prof. Daniel Harki, University of Minnesota, US

  • Advances in Targeted Protein Degradation
    Chair: Prof. Terry Moore, University of Illinois, US

  • A Focus on Early Career Investigators
    Chair: Dr Melissa Grenier-Davies, GlaxoSmithKline, US

  • Chemical Modulation of RNA
    Chair: Dr Darby Schmidt, Sonata Therapeutics, US

  • Computational Approaches to Identify and Target Cryptic and Allosteric Pockets
    Chair: Dr Malin Lemurell, AstraZeneca, SE
  • Drug Targets in GPCR Signalling
    Chair: Prof. György Keseru, Research Centre for Natural Sciences (RCNS), HU

  • Getting Out of the Starting Block: New Hit Finding and Chemotype Advancement Methods
    Chair: Dr Carolyn Dzierba, BMS, US
  • Organic Synthesis Impacting Medicinal Chemistry & Chemical Biology
    Chair: Prof. Rui Moreira, University of Lisbon, PT

  • Proximity-inducing Molecules and their Therapeutic Applications
    Chair: Dr Amit Choudhary, Broad Institute, US